March 24th, 2021: A Doctor's Note on COVID-19
This week during an Energy and Commerce hearing on the LIFT Act, I asked Dr. Tom Frieden about the importance of retaining health care staff in hospitals during the COVID-19 pandemic. Maintaining a strong health care workforce is critical to the health of this nation during normal times and especially during this public health emergency.
AstraZeneca announced its vaccine is 79% effective at preventing symptomatic COVID-19 and 100% effective in preventing serious disease and hospitalization.
Moderna announced it is beginning phase 2/3 of its COVID-19 vaccine in pediatric populations. Children ages 6 months to less than 12 years will be participating in the clinical trials.
- The White House will ship nearly 4 million doses of the AstraZeneca vaccine to Canada and Mexico. AstraZeneca’s vaccine has not yet been granted an Emergency Use Authorization in the U.S.
- The National Institute of Allergy and Infectious Diseases issued a statement including concerns on the information published by AstraZeneca on the initial data from its COVID-19 vaccine clinical trial, which may include outdated information.
Regeneron announced topline results from its Phase 3 trial studying REGEN-COV in high-risk non-hospitalized COVID-19 patients. Studies show REGEN-COV reduced hospitalization by 70% in COVID-19 patients.
The Centers for Disease Control and Prevention updated their Operational Strategy for K-12 Schools through Phased Prevention to reflect the latest science regarding physical distance between students in classrooms.
The Food and Drug Administration issued a revised fact sheet for health care providers including additional information on susceptibility of SARS-CoV-2 variants to each of the monoclonal antibody (mAb) therapies that are available through an Emergency Use Authorization for the treatment of COVID-19.
Starting March 29th,all adults in Texas will be eligible for the COVID-19 vaccine.
Week 16 COVID-19 vaccine allocations will be posted here.
Texas should reach 10 million COVID-19 doses administered by the end of this week.
Until next time, this is your doctor's note.
Congressman Michael C. Burgess, M.D.
|WASHINGTON, DC OFFICE
2161 Rayburn House Office Building
Washington, DC 20515
|LAKE DALLAS DISTRICT OFFICE
2000 South Stemmons Freeway, Suite 200
Lake Dallas, TX 75065